Metraipolis › archive › dc_afdbf11c72ef

Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic… — Europe PMC PMID:42077650

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42077650
DOI
10.1016/j.eclinm.2026.103831
License (as archived)
solo-consultazione
Archived
2026-11-01T08:07:50.712Z
SHA-256 of the archived text
ff8ec910573e2ba0c82952734725c5be13b50c61249cb6ac375f86ee08f33e27
Stable URL of this page
https://metraipolis.com/documento/dc_afdbf11c72ef

How to cite

Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic… — Europe PMC PMID:42077650 — Europe PMC (en), https://europepmc.org/article/MED/42077650 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afdbf11c72ef (Metraipolis archive dc_afdbf11c72ef, sha256 ff8ec910573e2ba0c82952734725c5be13b50c61249cb6ac375f86ee08f33e27)
BibTeX
@misc{dcafdbf11c72ef,
  title = {Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic… — Europe PMC PMID:42077650},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42077650},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afdbf11c72ef; sha256 ff8ec910573e2ba0c82952734725c5be13b50c61249cb6ac375f86ee08f33e27},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42077650. Agents can read the archived copy with the MCP tool read_document.